Renaissance Anlagestiftung has become a long-term majority shareholder in Baitella. Together with the management, Renaissance will continuously develop the globally successful quality products for applications in medicine and industry under the “Fisso” brand. A
Homburger acts as Swiss counsel to Axel Springer, a media and technology company active in more than 40 countries, in the acquisition of its shares by Ringiers in the joint venture Ringier Axel Springer Media, with
Relief Therapeutics Holding, a biopharmaceutical company seeking to provide patients therapeutic relief from serious diseases with high unmet need, has issued 1,000,000,000 additional registered shares out of the authorised share capital approved by the Annual
The Commons Project Foundation appointed Ruth Atherton (pictured), former deputy general counsel at the Bill & Melinda Gates Foundation, to the executive team as chief legal officer. The group is headquartered in Switzerland and launched
The University of St. Gallen has appointed Homburger partner Daniel Häusermann (pictured) as professor of private and business law, effective August 1, 2021. As partner at Homburger, Daniel Häusermann continues to practice public and private
On July 6, 2021, Baitella Beteiligungen AG, the holding company of Baitella AG, a leading provider of user-friendly, individualized holding system solutions with central clamping unit, was acquired by RN Acqui III SA, a subsidiary of Renaissance
Idorsia biopharmaceutical company has placed CHF 600 million senior unsecured convertible bonds due 2028 in a private placement with institutional investors. The net proceeds of the
Baitella Beteiligungen, the holding company of Baitella, a provider of user-friendly, individualized holding system solutions with central clamping unit, was acquired by RN Acqui III, a subsidiary of Renaissance Evergreen, for an undisclosed consideration. The
Julius Baer Group has finalized the acquisition of a 83% stake in Kuoni Mueller and Partner Holding, an integrated real estate service provider based in Zurich. Schellenberg Wittmer acted as legal counsel to Baer Group
H.C. Wainwright acted as sole placement agent in connection to the private placement of 71,428,572 shares in Relief Therapeutics Holding, a Swiss biopharmaceutical company listed at SIX Swiss Exchange, at a price of CHF 0.21 per
